Project Grant HT94252410028
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$552K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
The University of Florida was awarded a $5.796 million Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of September 1, 2023 through August 31, 2027. The grant will support the development of clinical candidates for the treatment of Myotonic Dystrophy at the University's location in Gainesville, Florida. As the prime awardee, the University will leverage its expertise in biomedical research to...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $276,721 to Florida State University to improve targeted ovarian cancer therapy using the novel Notch pathway inhibitor auranofin. The award period runs from July 1, 2024 to June 30, 2027. The funded research aims to advance the scientific understanding and development of innovative treatments for ovarian cancer, a critical medical challenge for military...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
This $692,208 federal Project Grant awarded by the Defense Advanced Research Projects Agency (DARPA) under the Department of Defense Basic Scientific Research program (CFDA 12.431) supports research and development of high-performance polymeric materials. The grant was awarded to the University of Florida's Division of Sponsored Research on August 9, 2024, with a performance period ending on August 8, 2025. The research aims to advance fundamental knowledge and develop capabilities with...
The Defense Health Agency awarded a $478,372.00 Project Grant to the University of Florida's Division of Sponsored Research to fund research under the Military Medical Research and Development (CFDA 12.420) program. The research aims to develop YAP/TEAD inhibitors for novel non-alcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC) therapeutics. The University of Florida has contracted with Tulane University to support research related to optimizing lead YAP/TEAD inhibitor...
The University of Maryland, Baltimore (UMB) was awarded a $587,271 Project Grant from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), to conduct research on "DUAL INHIBITION OF PARP AND IL-6 AS A NOVEL THERAPEUTIC APPROACH FOR BRCA-MUTATED TRIPLE-NEGATIVE BREAST CANCER." This research project will occur from July 1, 2024 to June 30, 2027. The Military Medical Research and Development program supports a...
This $1,347,118 Project Grant was awarded on May 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research conducted by the University of Miami to target KIF20A, a kinesin with a novel, non-canonical role in castration-resistant prostate cancer. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research investigating medical...
This federal Project Grant award, valued at $1,555,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the University of Wisconsin System's research initiative to develop population modeling to optimize equitable ovarian cancer outcomes. The project aims to transform healthcare for military service members and the broader public by advancing innovative research on disease prevention, diagnosis, and...
This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...